Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 20–20 | Cite as

Alendronic-acid/denosumab/teriparatide

Severe bone turnover suppression, atypical femoral fracture and increase in bone specific alkaline phosphatase and tartarate resistence acid phosphatase-5b: case report
Case report
  • 41 Downloads

Reference

  1. Yoshitani J, et al. Teriparatide treatment for an atypical femoral fracture in a patient with calcinosis cutis associated with juvenile dermatomyositis: A case report. Clinical Cases in Mineral and Bone Metabolism 15: 385-388, No. 3, Sep 2018. Available from: URL: https://www.researchgate.net/publication/333144657_Teriparatide_treatment_for_an_atypical_femoral_fracture_in_a_patient_with_calcinosis_cutis_associated_with_juvenile_dermatomyositis_A_case_report - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations